Sanofi
MODIFICATION OF ENGINEERED INFLUENZA HEMAGGLUTININ POLYPEPTIDES
Last updated:
Abstract:
The present invention provides, among other things, modified recombinant HA polypeptides with broadened immunogenic profile that extends coverage to antigenically distinct influenza strains and methods of making and using the same.
Status:
Application
Type:
Utility
Filling date:
2 Jun 2017
Issue date:
9 Jul 2020